Cargando…

Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation

Detalles Bibliográficos
Autores principales: Manfredi, Roberto, Calza, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315946/
http://dx.doi.org/10.1186/1742-4690-7-S1-P83
_version_ 1782228311224614912
author Manfredi, Roberto
Calza, Leonardo
author_facet Manfredi, Roberto
Calza, Leonardo
author_sort Manfredi, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-3315946
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33159462012-03-31 Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation Manfredi, Roberto Calza, Leonardo Retrovirology Poster Presentation BioMed Central 2010-05-11 /pmc/articles/PMC3315946/ http://dx.doi.org/10.1186/1742-4690-7-S1-P83 Text en Copyright ©2010 Manfredi and Calza; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Manfredi, Roberto
Calza, Leonardo
Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title_full Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title_fullStr Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title_full_unstemmed Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title_short Chronic HCV treatment with peginterferon-ribavirin and severe tuberculosis re-activation
title_sort chronic hcv treatment with peginterferon-ribavirin and severe tuberculosis re-activation
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315946/
http://dx.doi.org/10.1186/1742-4690-7-S1-P83
work_keys_str_mv AT manfrediroberto chronichcvtreatmentwithpeginterferonribavirinandseveretuberculosisreactivation
AT calzaleonardo chronichcvtreatmentwithpeginterferonribavirinandseveretuberculosisreactivation